Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
41
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Madryn Health Advisors, LP | 10% Owner | 12 | $1.50M | $0 | 2026-03-26 |
| Essex Woodlands IX, LLC | 10% Owner | 18 | $3.00M | $0 | 2026-03-26 |
| Madryn Asset Management, LP | 10% Owner | 3 | $0 | $0 | 2025-09-30 |
| Madryn Health Partners (Cayman Master), LP | 10% Owner | 3 | $0 | $0 | 2025-03-31 |
| Natale Anthony | Director | 40 | $0 | $82.7K | 2024-12-03 |
| Masters Michael Willingham | 10% Owner | 37 | $0 | $855.3K | 2024-10-03 |
| Madryn Health Partners, LP | 10% Owner | 1 | $0 | $0 | 2024-09-26 |
| EW Healthcare Partners, L.P. | 10% Owner | 3 | $4.90M | $0 | 2024-01-18 |
| EW Healthcare Partners-A, L.P. | 10% Owner | 5 | $15.50M | $0 | 2023-10-20 |
| MANDARELLO MICHAEL | General Counsel & Secretary | 12 | $0 | $0 | 2023-08-11 |
| Essex Woodlands Fund IX-GP, L.P. | 10% Owner | 5 | $6.00M | $0 | 2023-07-12 |
| PORTARO ROSS | President Global Sales | 11 | $89.2K | $0 | 2023-03-25 |
| Della Penna Domenic | Exec VP & General Manager | 16 | $131.6K | $0 | 2023-03-25 |
| Georgiadis Anna | VP, Global Human Resources | 11 | $9.1K | $0 | 2023-03-25 |
| MCGRAIL WILLIAM H | VP Regulatory Affairs | 7 | $0 | $0 | 2023-03-25 |
| HOLLMIG STANLEY TYLER | Director | 4 | $75.6K | $0 | 2023-03-24 |
| Lacchin Louise | Director | 6 | $0 | $0 | 2023-03-24 |
| Kong Garheng | Director, 10% Owner | 15 | $5.67M | $0 | 2023-03-24 |
| LaPorte Fritz L | Director | 7 | $0 | $0 | 2023-03-24 |
| Sullivan Keith J | Director | 10 | $100.0K | $40.4K | 2023-03-24 |
| BARRY RICHARD SCOTT | Director, 10% Owner | 25 | $21.40M | $0 | 2023-03-24 |
| Varghese Hemanth Jacob | President/Chief Bus. Officer | 2 | $50.0K | $0 | 2022-11-18 |
| HealthQuest Venture Management II, L.L.C. | 10% Owner | 5 | $3.67M | $0 | 2022-11-18 |
| DE SILVA RAJIV | Officer | 2 | $250.0K | $0 | 2022-11-18 |
| KOTLER ANAT | VP Global Marketing | 3 | $0 | $0 | 2022-11-10 |
| SHIMIZU KENJI | Interim CTO | 3 | $0 | $0 | 2022-11-10 |
| Iger Yoni | VP, RA/QA/Clinical Affairs | 10 | $10.1K | $0 | 2022-11-10 |
| Sinay Soren Maor | Chief Operating Officer | 13 | $0 | $0 | 2022-11-10 |
| Serafino Domenic | Chief Executive Officer | 23 | $271.7K | $0 | 2022-08-31 |
| HealthQuest Partners II, L.P. | 10% Owner | 5 | $2.00M | $0 | 2021-12-15 |
| SEDCO Capital Cayman Ltd | 10% Owner | 8 | $0 | $350.8K | 2021-07-12 |
| Saudi Economic & Development Securities Co | 10% Owner | 9 | $0 | $521.6K | 2021-07-08 |
| Zaring Chad A | Chief Commercial Officer | 6 | $192.6K | $0 | 2021-06-01 |
| Kang Melissa | VP, Global Marketing | 7 | $0 | $0 | 2021-03-26 |
| Vaynberg Boris | Chief Technology Officer | 8 | $0 | $0 | 2020-04-08 |
| Kelley William Bernard | President, Global Sales | 5 | $0 | $0 | 2020-03-30 |
| Di Sisto Domenic | General Counsel and Corp. Sec. | 4 | $0 | $0 | 2020-03-30 |
| Tammenoms Bakker Juliet | Director, 10% Owner | 4 | $0 | $0 | 2019-11-07 |
| InterWest Partners IX, LP | 10% Owner | 2 | $0 | $0 | 2019-11-07 |
| Kliman Gilbert H | Director, 10% Owner | 2 | $0 | $0 | 2019-11-07 |
| MOLL FREDERIC H | Director | 5 | $0 | $0 | 2019-11-07 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Essex Woodlands IX, LLC | 10% Owner | S Sale deriv | 2026-03-26 | 2026-03-27 | 1,500,000 | — | $0 | 0 | SEC↗ |
| Essex Woodlands IX, LLC | 10% Owner | S Sale deriv | 2026-03-26 | 2026-03-27 | 0 | — | $0 | 0 | SEC↗ |
| Essex Woodlands IX, LLC | 10% Owner | S Sale deriv | 2026-03-26 | 2026-03-27 | 1,575,810 | — | $0 | 0 | SEC↗ |
| Madryn Health Advisors, LP | 10% Owner | P Buy deriv | 2026-03-26 | 2026-03-30 | 1,500,000 | — | $0 | 1,500,000 | SEC↗ |
| Madryn Health Advisors, LP | 10% Owner | P Buy deriv | 2026-03-26 | 2026-03-30 | 335,000 | — | $0 | 1,835,000 | SEC↗ |
| Madryn Health Advisors, LP | 10% Owner | P Buy deriv | 2026-03-26 | 2026-03-30 | 0 | — | $0 | 0 | SEC↗ |
| Madryn Health Advisors, LP | 10% Owner | P Buy deriv | 2026-03-26 | 2026-03-30 | 1,575,810 | — | $0 | 1,575,810 | SEC↗ |
| Madryn Health Advisors, LP | 10% Owner | P Buy | 2026-03-26 | 2026-03-30 | 37,187 | — | $0 | 37,547,373 | SEC↗ |
| Madryn Health Advisors, LP | 10% Owner | P Buy | 2026-03-26 | 2026-03-30 | 37,500,000 | $0.04 | $1.50M | 37,510,186 | SEC↗ |
| Madryn Asset Management, LP | 10% Owner | D To issuer deriv | 2025-09-30 | 2025-10-02 | 545,335 | — | $0 | 0 | SEC↗ |
| Madryn Asset Management, LP | 10% Owner | P Buy deriv | 2025-09-30 | 2025-10-02 | 0 | — | $0 | 2,030,866 | SEC↗ |
| Madryn Health Advisors, LP | 10% Owner | P Buy deriv | 2025-06-30 | 2025-07-02 | 325,651 | — | $0 | 0 | SEC↗ |
| Madryn Health Advisors, LP | 10% Owner | D To issuer deriv | 2025-06-30 | 2025-07-02 | 0 | — | $0 | 1,485,531 | SEC↗ |
| Madryn Health Advisors, LP | 10% Owner | P Buy deriv | 2025-06-30 | 2025-07-02 | 0 | — | $0 | 0 | SEC↗ |
| Madryn Health Partners (Cayman | 10% Owner | P Buy deriv | 2025-03-31 | 2025-04-02 | 379,311 | — | $0 | 1,159,880 | SEC↗ |
| Madryn Health Partners (Cayman | 10% Owner | D To issuer deriv | 2025-03-31 | 2025-04-02 | 0 | — | $0 | 0 | SEC↗ |
| Madryn Health Partners (Cayman | 10% Owner | P Buy deriv | 2025-03-31 | 2025-04-02 | 0 | — | $0 | 0 | SEC↗ |
| Natale Anthony | Director | S Sale | 2024-12-03 | 2024-12-04 | 42,768 | $0.31 | $13.3K | 0 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-10-03 | 2024-10-07 | 7,594 | $0.53 | $4.0K | 27,470 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-10-03 | 2024-10-07 | 60,272 | $0.53 | $31.9K | 209,803 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-10-03 | 2024-10-07 | 40,434 | $0.53 | $21.4K | 146,257 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-10-03 | 2024-10-07 | 3,695 | $0.53 | $2.0K | 13,364 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-10-03 | 2024-10-07 | 50,901 | $0.53 | $27.0K | 184,122 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-10-02 | 2024-10-02 | 2,144 | $0.53 | $1.1K | 17,059 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-10-02 | 2024-10-02 | 23,470 | $0.53 | $12.4K | 186,691 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-10-02 | 2024-10-02 | 29,546 | $0.53 | $15.7K | 235,023 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-10-02 | 2024-10-02 | 34,985 | $0.53 | $18.5K | 270,075 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-10-02 | 2024-10-02 | 4,408 | $0.53 | $2.3K | 35,064 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-10-01 | 2024-10-02 | 51,879 | $0.60 | $31.1K | 305,060 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-10-01 | 2024-10-02 | 6,537 | $0.60 | $3.9K | 39,472 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-10-01 | 2024-10-02 | 3,180 | $0.60 | $1.9K | 19,203 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-10-01 | 2024-10-02 | 34,804 | $0.60 | $20.9K | 210,161 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-10-01 | 2024-10-02 | 43,814 | $0.60 | $26.3K | 264,569 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-09-30 | 2024-10-02 | 26,406 | $0.64 | $16.9K | 356,939 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-09-30 | 2024-10-02 | 3,327 | $0.64 | $2.1K | 46,009 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-09-30 | 2024-10-02 | 1,619 | $0.64 | $1.0K | 22,383 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-09-30 | 2024-10-02 | 17,715 | $0.64 | $11.3K | 244,965 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-09-30 | 2024-10-02 | 22,301 | $0.64 | $14.3K | 308,383 | SEC↗ |
| Madryn Health Partners, LP | 10% Owner | P Buy deriv | 2024-09-26 | 2024-09-30 | 203,583 | — | $0 | 780,569 | SEC↗ |
| Masters Michael Willingham | 10% Owner | C Conversion deriv | 2024-06-11 | 2024-06-12 | 350,000 | — | $0 | 0 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-06-11 | 2024-06-12 | 102,717 | $1.20 | $123.3K | 383,345 | SEC↗ |
| Masters Michael Willingham | 10% Owner | C Conversion | 2024-06-11 | 2024-06-12 | 233,345 | — | $0 | 486,062 | SEC↗ |
| Masters Michael Willingham | 10% Owner | C Conversion deriv | 2024-06-10 | 2024-06-12 | 74,000 | — | $0 | 0 | SEC↗ |
| Masters Michael Willingham | 10% Owner | C Conversion deriv | 2024-06-10 | 2024-06-12 | 496,000 | — | $0 | 0 | SEC↗ |
| Masters Michael Willingham | 10% Owner | C Conversion deriv | 2024-06-10 | 2024-06-12 | 394,000 | — | $0 | 0 | SEC↗ |
| Masters Michael Willingham | 10% Owner | C Conversion deriv | 2024-06-10 | 2024-06-12 | 36,000 | — | $0 | 0 | SEC↗ |
| Masters Michael Willingham | 10% Owner | C Conversion | 2024-06-10 | 2024-06-12 | 49,336 | — | $0 | 49,336 | SEC↗ |
| Masters Michael Willingham | 10% Owner | C Conversion | 2024-06-10 | 2024-06-12 | 24,002 | — | $0 | 24,002 | SEC↗ |
| Masters Michael Willingham | 10% Owner | C Conversion | 2024-06-10 | 2024-06-12 | 330,684 | — | $0 | 330,684 | SEC↗ |
| Masters Michael Willingham | 10% Owner | C Conversion | 2024-06-10 | 2024-06-12 | 262,680 | — | $0 | 262,680 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-06-07 | 2024-06-12 | 172,314 | $1.20 | $206.8K | 0 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-06-07 | 2024-06-12 | 128,254 | $1.20 | $153.9K | 0 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-06-07 | 2024-06-12 | 11,467 | $1.20 | $13.8K | 0 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-06-07 | 2024-06-12 | 1,487 | $1.20 | $1.8K | 0 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-06-07 | 2024-06-12 | 19,814 | $1.20 | $23.8K | 0 | SEC↗ |
| Masters Michael Willingham | 10% Owner | S Sale | 2024-06-07 | 2024-06-12 | 53,895 | $1.22 | $65.8K | 252,717 | SEC↗ |
| Madryn Asset Management, LP | 10% Owner | P Buy deriv | 2024-05-24 | 2024-05-29 | 576,986 | — | $0 | 576,986 | SEC↗ |
| EW Healthcare Partners, L.P. | 10% Owner | P Buy deriv | 2024-01-18 | 2024-01-19 | 0 | — | $0 | 0 | SEC↗ |
| EW Healthcare Partners-A, L.P. | 10% Owner | P Buy deriv | 2023-10-20 | 2023-10-20 | 502,513 | $3.98 | $2.00M | 1,575,810 | SEC↗ |
| Madryn Health Advisors, LP | 10% Owner | P Buy deriv | 2023-10-04 | 2023-10-06 | 0 | — | $0 | 0 | SEC↗ |
| Madryn Health Advisors, LP | 10% Owner | D To issuer deriv | 2023-10-04 | 2023-10-06 | 0 | — | $0 | 0 | SEC↗ |
| Madryn Health Advisors, LP | 10% Owner | P Buy deriv | 2023-10-04 | 2023-10-06 | 248,755 | — | $0 | 248,755 | SEC↗ |
| Essex Woodlands IX, LLC | 10% Owner | P Buy deriv | 2023-09-08 | 2023-09-12 | 292,398 | $3.42 | $1.00M | 1,073,297 | SEC↗ |
| MANDARELLO MICHAEL | General Counsel & Secretary | F Tax w/h | 2023-08-11 | 2023-08-15 | 233 | — | $0 | 1,491 | SEC↗ |
| MANDARELLO MICHAEL | General Counsel & Secretary | A Award | 2023-08-11 | 2023-08-15 | 834 | — | $0 | 1,724 | SEC↗ |
| Essex Woodlands Fund IX-GP, L. | 10% Owner | P Buy deriv | 2023-07-12 | 2023-07-13 | 500,000 | — | $0 | 780,899 | SEC↗ |
| Essex Woodlands IX, LLC | 10% Owner | P Buy deriv | 2023-05-15 | 2023-05-17 | 280,899 | $7.12 | $2.00M | 280,899 | SEC↗ |
| PORTARO ROSS | Exec VP & General Manager | A Award | 2023-03-25 | 2023-03-28 | 25,000 | — | $0 | 145,000 | SEC↗ |
| PORTARO ROSS | Exec VP & General Manager | F Tax w/h | 2023-03-25 | 2023-03-28 | 11,034 | — | $0 | 133,966 | SEC↗ |
| MCGRAIL WILLIAM H | Sr. VP | A Award | 2023-03-25 | 2023-03-28 | 12,500 | — | $0 | 12,500 | SEC↗ |
| MCGRAIL WILLIAM H | Sr. VP | F Tax w/h | 2023-03-25 | 2023-03-28 | 4,717 | — | $0 | 7,783 | SEC↗ |
| Georgiadis Anna | Chief HR Officer | F Tax w/h | 2023-03-25 | 2023-03-28 | 5,873 | — | $0 | 12,877 | SEC↗ |
| Georgiadis Anna | Chief HR Officer | A Award | 2023-03-25 | 2023-03-28 | 18,750 | — | $0 | 18,750 | SEC↗ |
| Della Penna Domenic | Exec VP & General Manager | A Award | 2023-03-25 | 2023-03-28 | 37,500 | — | $0 | 164,163 | SEC↗ |
| Della Penna Domenic | Exec VP & General Manager | F Tax w/h | 2023-03-25 | 2023-03-28 | 12,778 | — | $0 | 151,385 | SEC↗ |
| MANDARELLO MICHAEL | General Counsel & Secretary | A Award | 2023-03-25 | 2023-03-28 | 18,750 | — | $0 | 18,750 | SEC↗ |
| MANDARELLO MICHAEL | General Counsel & Secretary | F Tax w/h | 2023-03-25 | 2023-03-28 | 5,409 | — | $0 | 13,341 | SEC↗ |
| PORTARO ROSS | Exec VP & General Manager | A Award deriv | 2023-03-24 | 2023-03-28 | 200,000 | — | $0 | 200,000 | SEC↗ |
| MCGRAIL WILLIAM H | Sr. VP | A Award deriv | 2023-03-24 | 2023-03-28 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Georgiadis Anna | Chief HR Officer | A Award deriv | 2023-03-24 | 2023-03-28 | 200,000 | — | $0 | 200,000 | SEC↗ |
| HOLLMIG STANLEY TYLER | Director | A Award deriv | 2023-03-24 | 2023-03-28 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Kong Garheng | Director | A Award deriv | 2023-03-24 | 2023-03-28 | 75,000 | — | $0 | 75,000 | SEC↗ |
| BARRY RICHARD SCOTT | Director | A Award deriv | 2023-03-24 | 2023-03-28 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Della Penna Domenic | Exec VP & General Manager | A Award deriv | 2023-03-24 | 2023-03-28 | 250,000 | — | $0 | 250,000 | SEC↗ |
| MANDARELLO MICHAEL | General Counsel & Secretary | A Award deriv | 2023-03-24 | 2023-03-28 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Sullivan Keith J | Director | P Buy deriv | 2023-03-24 | 2023-03-28 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Natale Anthony | Director | A Award deriv | 2023-03-24 | 2023-03-28 | 75,000 | — | $0 | 75,000 | SEC↗ |
| LaPorte Fritz L | Director | A Award deriv | 2023-03-24 | 2023-03-28 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Lacchin Louise | Director | A Award deriv | 2023-03-24 | 2023-03-28 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Natale Anthony | Director | S Sale | 2022-11-29 | 2022-11-30 | 51,431 | $0.24 | $12.3K | 641,507 | SEC↗ |
| Natale Anthony | Director | S Sale | 2022-11-28 | 2022-11-30 | 51,428 | $0.27 | $13.9K | 692,938 | SEC↗ |
| Natale Anthony | Director | S Sale | 2022-11-25 | 2022-11-25 | 51,428 | $0.31 | $15.9K | 744,366 | SEC↗ |
| Natale Anthony | Director | S Sale | 2022-11-23 | 2022-11-25 | 51,428 | $0.33 | $17.0K | 795,794 | SEC↗ |
| Natale Anthony | Director | S Sale | 2022-11-22 | 2022-11-25 | 51,428 | $0.20 | $10.3K | 847,222 | SEC↗ |
| PORTARO ROSS | President Global Sales | P Buy | 2022-11-21 | 2022-11-22 | 60,000 | $0.22 | $13.2K | 120,000 | SEC↗ |
| Essex Woodlands Fund IX-GP, L. | 10% Owner | P Buy deriv | 2022-11-18 | 2022-11-22 | 1,441,985 | $2.00 | $2.88M | 1,441,985 | SEC↗ |
| Essex Woodlands Fund IX-GP, L. | 10% Owner | P Buy deriv | 2022-11-18 | 2022-11-22 | 58,015 | $2.00 | $116.0K | 58,015 | SEC↗ |
| HealthQuest Venture Management | 10% Owner | P Buy deriv | 2022-11-18 | 2022-11-22 | 335,000 | $2.00 | $670.0K | 335,000 | SEC↗ |
| BARRY RICHARD SCOTT | Director, 10% Owner | P Buy deriv | 2022-11-18 | 2022-11-22 | 58,015 | $2.00 | $116.0K | 58,015 | SEC↗ |
| BARRY RICHARD SCOTT | Director, 10% Owner | P Buy deriv | 2022-11-18 | 2022-11-22 | 1,441,985 | $2.00 | $2.88M | 1,441,985 | SEC↗ |
| Kong Garheng | Director, 10% Owner | P Buy deriv | 2022-11-18 | 2022-11-22 | 335,000 | $2.00 | $670.0K | 335,000 | SEC↗ |
| Essex Woodlands Fund IX-GP, L. | 10% Owner | P Buy deriv | 2022-11-18 | 2022-11-22 | 1,441,985 | $2.00 | $2.88M | 1,441,985 | SEC↗ |
| Essex Woodlands Fund IX-GP, L. | 10% Owner | P Buy deriv | 2022-11-18 | 2022-11-22 | 58,015 | $2.00 | $116.0K | 58,015 | SEC↗ |
| DE SILVA RAJIV | Officer | P Buy | 2022-11-18 | 2022-11-22 | 1,250,000 | $0.20 | $250.0K | 1,250,000 | SEC↗ |
| Varghese Hemanth Jacob | President/Chief Bus. Officer | P Buy | 2022-11-18 | 2022-11-22 | 250,000 | $0.20 | $50.0K | 250,000 | SEC↗ |
| HOLLMIG STANLEY TYLER | Director | P Buy | 2022-11-18 | 2022-11-22 | 250,000 | $0.20 | $50.0K | 290,000 | SEC↗ |
| Georgiadis Anna | VP, Global HR | A Award deriv | 2022-11-10 | 2022-11-14 | 100,000 | — | $0 | 100,000 | SEC↗ |
| PORTARO ROSS | President Global Sales | A Award deriv | 2022-11-10 | 2022-11-14 | 100,000 | — | $0 | 100,000 | SEC↗ |
| KOTLER ANAT | Interim VP, Global Marketing | A Award deriv | 2022-11-10 | 2022-11-14 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Iger Yoni | VP, RA/QA/Clinical Affairs | A Award deriv | 2022-11-10 | 2022-11-14 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MANDARELLO MICHAEL | General Counsel | A Award deriv | 2022-11-10 | 2022-11-14 | 100,000 | — | $0 | 100,000 | SEC↗ |
| SHIMIZU KENJI | Interim CTO | A Award deriv | 2022-11-10 | 2022-11-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MCGRAIL WILLIAM H | VP Regulatory Affairs | A Award deriv | 2022-11-10 | 2022-11-14 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Sinay Soren Maor | COO | A Award deriv | 2022-11-10 | 2022-11-14 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Della Penna Domenic | Chief Financial Officer | A Award deriv | 2022-11-10 | 2022-11-14 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Varghese Hemanth Jacob | President/Chief Bus. Officer | A Award deriv | 2022-10-17 | 2022-10-17 | 1,100,000 | — | $0 | 1,100,000 | SEC↗ |
| DE SILVA RAJIV | Chief Executive Officer | A Award deriv | 2022-10-02 | 2022-10-04 | 3,300,000 | — | $0 | 3,300,000 | SEC↗ |
| Della Penna Domenic | Chief Financial Officer | P Buy | 2022-09-16 | 2022-09-19 | 30,000 | $0.60 | $18.0K | 126,663 | SEC↗ |
| Della Penna Domenic | Chief Financial Officer | P Buy | 2022-09-16 | 2022-09-19 | 30,000 | $0.58 | $17.4K | 96,663 | SEC↗ |
| Georgiadis Anna | VP, Global HR | P Buy | 2022-09-12 | 2022-09-13 | 12,782 | $0.71 | $9.1K | 12,782 | SEC↗ |
| Serafino Domenic | Chief Executive Officer | P Buy | 2022-08-31 | 2022-08-31 | 37,500 | $0.33 | $12.4K | 1,008,758 | SEC↗ |
| Serafino Domenic | Chief Executive Officer | P Buy | 2022-08-30 | 2022-08-31 | 37,500 | $0.34 | $12.8K | 971,258 | SEC↗ |
| MANDARELLO MICHAEL | General Counsel | A Award deriv | 2022-08-11 | 2022-08-12 | 12,500 | — | $0 | 12,500 | SEC↗ |
| MANDARELLO MICHAEL | General Counsel | A Award deriv | 2022-08-11 | 2022-08-12 | 50,000 | — | $0 | 50,000 | SEC↗ |
| HOLLMIG STANLEY TYLER | Director | P Buy | 2022-05-24 | 2022-05-26 | 40,000 | $0.64 | $25.6K | 40,000 | SEC↗ |
| Serafino Domenic | Chief Executive Officer | P Buy | 2022-05-20 | 2022-05-23 | 65,000 | $0.75 | $48.8K | 933,758 | SEC↗ |
| PORTARO ROSS | President Global Sales | P Buy | 2022-05-17 | 2022-05-17 | 10,000 | $0.85 | $8.5K | 60,000 | SEC↗ |
| Sullivan Keith J | Director | A Award deriv | 2022-03-25 | 2022-03-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BARRY RICHARD SCOTT | Director | A Award deriv | 2022-03-25 | 2022-03-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Lacchin Louise | Director | A Award deriv | 2022-03-25 | 2022-03-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| HOLLMIG STANLEY TYLER | Director | A Award deriv | 2022-03-25 | 2022-03-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Kong Garheng | Director | A Award deriv | 2022-03-25 | 2022-03-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LaPorte Fritz L | Director | A Award deriv | 2022-03-25 | 2022-03-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Natale Anthony | Director | A Award deriv | 2022-03-25 | 2022-03-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MANDARELLO MICHAEL | General Counsel | A Award deriv | 2022-03-25 | 2022-03-28 | 18,750 | — | $0 | 18,750 | SEC↗ |
| MANDARELLO MICHAEL | General Counsel | A Award deriv | 2022-03-25 | 2022-03-28 | 56,250 | — | $0 | 56,250 | SEC↗ |
| Serafino Domenic | Chief Executive Officer | A Award deriv | 2022-03-25 | 2022-03-28 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Serafino Domenic | Chief Executive Officer | P Buy deriv | 2022-03-25 | 2022-03-28 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Della Penna Domenic | Chief Financial Officer | A Award deriv | 2022-03-25 | 2022-03-28 | 112,500 | — | $0 | 112,500 | SEC↗ |
| Della Penna Domenic | Chief Financial Officer | A Award deriv | 2022-03-25 | 2022-03-28 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Sinay Soren Maor | COO | A Award deriv | 2022-03-25 | 2022-03-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Sinay Soren Maor | COO | A Award deriv | 2022-03-25 | 2022-03-28 | 75,000 | — | $0 | 75,000 | SEC↗ |
| PORTARO ROSS | President Global Sales | A Award deriv | 2022-03-25 | 2022-03-28 | 75,000 | — | $0 | 75,000 | SEC↗ |
| PORTARO ROSS | President Global Sales | A Award deriv | 2022-03-25 | 2022-03-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Iger Yoni | VP Scientific Affairs | A Award deriv | 2022-03-25 | 2022-03-28 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Iger Yoni | VP Scientific Affairs | A Award deriv | 2022-03-25 | 2022-03-28 | 12,500 | — | $0 | 12,500 | SEC↗ |
| KOTLER ANAT | VP Global Marketing | A Award deriv | 2022-03-25 | 2022-03-28 | 37,500 | — | $0 | 37,500 | SEC↗ |
| KOTLER ANAT | VP Global Marketing | A Award deriv | 2022-03-25 | 2022-03-28 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Georgiadis Anna | VP, Global HR | A Award deriv | 2022-03-25 | 2022-03-28 | 18,750 | — | $0 | 18,750 | SEC↗ |
| Georgiadis Anna | VP, Global HR | A Award deriv | 2022-03-25 | 2022-03-28 | 56,250 | — | $0 | 56,250 | SEC↗ |
| SHIMIZU KENJI | Int. Chief Innovation Office | A Award deriv | 2022-03-25 | 2022-03-28 | 56,250 | — | $0 | 56,250 | SEC↗ |
| SHIMIZU KENJI | Int. Chief Innovation Office | A Award deriv | 2022-03-25 | 2022-03-28 | 18,750 | — | $0 | 18,750 | SEC↗ |
| MCGRAIL WILLIAM H | VP Regulatory Affairs | A Award deriv | 2022-03-25 | 2022-03-28 | 37,500 | — | $0 | 37,500 | SEC↗ |
| MCGRAIL WILLIAM H | VP Regulatory Affairs | A Award deriv | 2022-03-25 | 2022-03-28 | 12,500 | — | $0 | 12,500 | SEC↗ |
| PORTARO ROSS | President Global Sales | P Buy | 2021-12-16 | 2021-12-20 | 20,000 | $1.35 | $27.0K | 50,000 | SEC↗ |
| Kong Garheng | Director, 10% Owner | P Buy | 2021-12-15 | 2021-12-17 | 1,600,000 | $1.25 | $2.00M | 6,795,621 | SEC↗ |
| Sullivan Keith J | Director | P Buy | 2021-12-15 | 2021-12-17 | 80,000 | $1.25 | $100.0K | 80,000 | SEC↗ |
| HealthQuest Partners II, L.P. | 10% Owner | P Buy | 2021-12-15 | 2021-12-17 | 1,600,000 | $1.25 | $2.00M | 6,795,621 | SEC↗ |
| BARRY RICHARD SCOTT | Director, 10% Owner | P Buy | 2021-12-15 | 2021-12-17 | 3,768,388 | $1.25 | $4.71M | 15,705,966 | SEC↗ |
| BARRY RICHARD SCOTT | Director, 10% Owner | P Buy | 2021-12-15 | 2021-12-17 | 151,612 | $1.25 | $189.5K | 16,337,856 | SEC↗ |
| EW Healthcare Partners, L.P. | 10% Owner | P Buy | 2021-12-15 | 2021-12-17 | 151,612 | $1.25 | $189.5K | 16,337,856 | SEC↗ |
| EW Healthcare Partners, L.P. | 10% Owner | P Buy | 2021-12-15 | 2021-12-17 | 3,768,388 | $1.25 | $4.71M | 15,705,966 | SEC↗ |
| PORTARO ROSS | President Global Sales | P Buy | 2021-12-03 | 2021-12-06 | 30,000 | $1.35 | $40.5K | 30,000 | SEC↗ |
| Chief Executive Officer | P Buy | 2021-12-01 | 2021-12-01 | 37,500 | $1.32 | $49.5K | 868,758 | SEC↗ | |
| Serafino Domenic | Chief Executive Officer | P Buy | 2021-11-19 | 2021-11-19 | 17,000 | $1.48 | $25.2K | 831,258 | SEC↗ |
| Serafino Domenic | Chief Executive Officer | P Buy | 2021-11-17 | 2021-11-18 | 15,500 | $1.60 | $24.8K | 814,258 | SEC↗ |
| PORTARO ROSS | President Global Sales | A Award deriv | 2021-11-12 | 2021-11-17 | 200,000 | — | $0 | 200,000 | SEC↗ |
| MANDARELLO MICHAEL | General Counsel | A Award deriv | 2021-11-12 | 2021-11-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MCGRAIL WILLIAM H | VP Regulatory Affairs | A Award deriv | 2021-11-12 | 2021-11-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MANDARELLO MICHAEL | General Counsel | A Award deriv | 2021-11-12 | 2021-11-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Georgiadis Anna | VP, Global HR | A Award deriv | 2021-11-12 | 2021-11-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Iger Yoni | VP, RA/QA/Clinical Affairs | P Buy | 2021-08-18 | 2021-08-20 | 5,181 | $1.94 | $10.1K | 5,181 | SEC↗ |
| SEDCO Capital Cayman Ltd | 10% Owner | S Sale | 2021-07-12 | 2021-07-13 | 19,941 | $3.25 | $64.8K | 922,456 | SEC↗ |
| SEDCO Capital Cayman Ltd | 10% Owner | S Sale | 2021-07-12 | 2021-07-13 | 30,059 | $3.25 | $97.7K | 942,397 | SEC↗ |
| SEDCO Capital Cayman Ltd | 10% Owner | S Sale | 2021-07-09 | 2021-07-12 | 50,000 | $3.24 | $162.0K | 980,389 | SEC↗ |
| SEDCO Capital Cayman Ltd | 10% Owner | S Sale | 2021-07-09 | 2021-07-12 | 7,933 | $3.32 | $26.3K | 972,456 | SEC↗ |
| Saudi Economic & Development S | 10% Owner | S Sale | 2021-07-08 | 2021-07-12 | 6,426 | $3.20 | $20.6K | 1,030,389 | SEC↗ |
| Saudi Economic & Development S | 10% Owner | S Sale | 2021-07-08 | 2021-07-12 | 50,000 | $3.20 | $160.0K | 1,080,389 | SEC↗ |
| Saudi Economic & Development S | 10% Owner | S Sale | 2021-07-08 | 2021-07-12 | 8,516 | $3.22 | $27.4K | 1,071,873 | SEC↗ |
| Saudi Economic & Development S | 10% Owner | S Sale | 2021-07-08 | 2021-07-12 | 35,058 | $3.20 | $112.2K | 1,036,815 | SEC↗ |
| Saudi Economic & Development S | 10% Owner | S Sale | 2021-07-02 | 2021-07-06 | 14,679 | $3.20 | $47.0K | 1,130,389 | SEC↗ |
| Saudi Economic & Development S | 10% Owner | S Sale | 2021-07-01 | 2021-07-06 | 4,911 | $3.20 | $15.7K | 1,145,068 | SEC↗ |
| Saudi Economic & Development S | 10% Owner | S Sale | 2021-07-01 | 2021-07-06 | 8,364 | $3.20 | $26.8K | 1,168,323 | SEC↗ |
| Saudi Economic & Development S | 10% Owner | S Sale | 2021-07-01 | 2021-07-06 | 18,344 | $3.20 | $58.7K | 1,149,979 | SEC↗ |
| Saudi Economic & Development S | 10% Owner | S Sale | 2021-06-28 | 2021-06-30 | 16,646 | $3.20 | $53.3K | 1,176,687 | SEC↗ |
| Della Penna Domenic | Chief Financial Officer | P Buy | 2021-06-15 | 2021-06-16 | 25,000 | $2.39 | $59.8K | 66,663 | SEC↗ |
| Della Penna Domenic | Chief Financial Officer | P Buy | 2021-06-15 | 2021-06-16 | 15,000 | $2.43 | $36.5K | 41,663 | SEC↗ |
| Serafino Domenic | Chief Executive Officer | P Buy | 2021-06-14 | 2021-06-15 | 40,000 | $2.46 | $98.4K | 798,758 | SEC↗ |
| Zaring Chad A | CCO | P Buy | 2021-06-01 | 2021-06-03 | 40,000 | $2.09 | $83.6K | 80,000 | SEC↗ |
| Iger Yoni | VP, RA/QA/Clinical Affairs | A Award deriv | 2021-03-26 | 2021-08-20 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Iger Yoni | VP, RA/QA/Clinical Affairs | A Award deriv | 2021-03-26 | 2021-03-30 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Sinay Soren Maor | COO | A Award deriv | 2021-03-26 | 2021-03-30 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Serafino Domenic | Chief Executive Officer | A Award deriv | 2021-03-26 | 2021-03-30 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Della Penna Domenic | Chief Financial Officer | A Award deriv | 2021-03-26 | 2021-03-30 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Kang Melissa | VP, Global Marketing | A Award deriv | 2021-03-26 | 2021-03-30 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Sullivan Keith J | Director | A Award deriv | 2021-03-26 | 2021-03-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Zaring Chad A | CCO | A Award deriv | 2021-03-26 | 2021-03-30 | 100,000 | — | $0 | 100,000 | SEC↗ |
| BARRY RICHARD SCOTT | Director, 10% Owner | A Award deriv | 2021-03-26 | 2021-03-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Georgiadis Anna | VP, Global HR | A Award deriv | 2021-03-26 | 2021-03-30 | 70,000 | — | $0 | 70,000 | SEC↗ |
| LaPorte Fritz L | Director | A Award deriv | 2021-03-26 | 2021-03-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Kong Garheng | Director, 10% Owner | A Award deriv | 2021-03-26 | 2021-03-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Natale Anthony | Director | A Award deriv | 2021-03-26 | 2021-03-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Serafino Domenic | Chief Executive Officer | M Exercise deriv | 2020-11-20 | 2020-11-24 | 15,586 | — | $0 | 0 | SEC↗ |
| Serafino Domenic | Chief Executive Officer | M Exercise deriv | 2020-11-20 | 2020-11-24 | 311,003 | — | $0 | 0 | SEC↗ |
| Serafino Domenic | Chief Executive Officer | M Exercise | 2020-11-20 | 2020-11-24 | 15,586 | $1.35 | $21.0K | 15,586 | SEC↗ |
| Serafino Domenic | Chief Executive Officer | M Exercise | 2020-11-20 | 2020-11-24 | 311,003 | $0.45 | $140.0K | 758,758 | SEC↗ |
| Zaring Chad A | Chief Commercial Officer | P Buy | 2020-08-24 | 2020-08-25 | 18,950 | $2.74 | $51.9K | 40,000 | SEC↗ |
| Zaring Chad A | Chief Commercial Officer | P Buy | 2020-08-21 | 2020-08-25 | 21,050 | $2.71 | $57.0K | 21,050 | SEC↗ |
| Kong Garheng | Director, 10% Owner | C Conversion deriv | 2020-06-16 | 2020-06-18 | 120,000 | — | $0 | 0 | SEC↗ |
| BARRY RICHARD SCOTT | Director, 10% Owner | C Conversion deriv | 2020-06-16 | 2020-06-18 | 20,885 | — | $0 | 0 | SEC↗ |
| BARRY RICHARD SCOTT | Director, 10% Owner | C Conversion deriv | 2020-06-16 | 2020-06-18 | 519,115 | — | $0 | 0 | SEC↗ |
| Essex Woodlands IX, LLC | 10% Owner | C Conversion deriv | 2020-06-16 | 2020-06-18 | 20,885 | — | $0 | 0 | SEC↗ |
| Essex Woodlands IX, LLC | 10% Owner | C Conversion deriv | 2020-06-16 | 2020-06-18 | 519,115 | — | $0 | 0 | SEC↗ |
| HealthQuest Venture Management | 10% Owner | C Conversion deriv | 2020-06-16 | 2020-06-18 | 120,000 | — | $0 | 0 | SEC↗ |
| Kong Garheng | Director, 10% Owner | C Conversion | 2020-06-16 | 2020-06-18 | 1,200,000 | — | $0 | 5,195,621 | SEC↗ |
| BARRY RICHARD SCOTT | Director, 10% Owner | C Conversion | 2020-06-16 | 2020-06-18 | 208,853 | — | $0 | 12,417,856 | SEC↗ |
| BARRY RICHARD SCOTT | Director, 10% Owner | C Conversion | 2020-06-16 | 2020-06-18 | 5,191,147 | — | $0 | 12,209,003 | SEC↗ |
| Essex Woodlands IX, LLC | 10% Owner | C Conversion | 2020-06-16 | 2020-06-18 | 208,853 | — | $0 | 12,417,856 | SEC↗ |
| Essex Woodlands IX, LLC | 10% Owner | C Conversion | 2020-06-16 | 2020-06-18 | 5,191,147 | — | $0 | 12,209,003 | SEC↗ |
| HealthQuest Venture Management | 10% Owner | C Conversion | 2020-06-16 | 2020-06-18 | 1,200,000 | — | $0 | 5,195,612 | SEC↗ |
| Iger Yoni | VP Clinical & Reg. Affairs, | A Award deriv | 2020-04-08 | 2020-04-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Vaynberg Boris | Chief Technology Officer | A Award deriv | 2020-04-08 | 2020-04-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Vaynberg Boris | Chief Technology Officer | A Award deriv | 2020-03-30 | 2020-04-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Kelley William Bernard | President, Global Sales | A Award deriv | 2020-03-30 | 2020-04-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Della Penna Domenic | Chief Financial Officer | A Award deriv | 2020-03-30 | 2020-04-01 | 150,000 | — | $0 | 150,000 | SEC↗ |
| LaPorte Fritz L | Director | A Award deriv | 2020-03-30 | 2020-04-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Sullivan Keith J | Director | A Award deriv | 2020-03-30 | 2020-04-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Serafino Domenic | Chief Executive Officer | A Award deriv | 2020-03-30 | 2020-04-01 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Sinay Soren Maor | Chief Operating Officer | A Award deriv | 2020-03-30 | 2020-04-01 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Kang Melissa | VP, Global Marketing | A Award deriv | 2020-03-30 | 2020-04-01 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Di Sisto Domenic | General Counsel and Corp. Se | A Award deriv | 2020-03-30 | 2020-04-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Georgiadis Anna | VP, Global Human Resources | A Award deriv | 2020-03-30 | 2020-04-01 | 70,000 | — | $0 | 70,000 | SEC↗ |
| BARRY RICHARD SCOTT | Director, 10% Owner | A Award deriv | 2020-03-30 | 2020-04-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Iger Yoni | VP Clinical & Reg. Affairs, | A Award deriv | 2020-03-30 | 2020-04-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Lacchin Louise | Director | A Award deriv | 2020-03-30 | 2020-04-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Kong Garheng | Director, 10% Owner | A Award deriv | 2020-03-30 | 2020-04-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Natale Anthony | Director | A Award deriv | 2020-03-30 | 2020-04-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Zaring Chad A | Chief Commercial Officer | A Award deriv | 2020-03-30 | 2020-04-01 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SEDCO Capital Cayman Ltd | 10% Owner | A Award deriv | 2020-03-18 | 2020-03-19 | 1,600,000 | — | $0 | 1,200,000 | SEC↗ |
| SEDCO Capital Cayman Ltd | 10% Owner | A Award deriv | 2020-03-18 | 2020-03-19 | 660,000 | — | $0 | 495,000 | SEC↗ |
| EW Healthcare Partners-A, L.P. | 10% Owner | P Buy deriv | 2020-03-18 | 2020-03-20 | 3,893,360 | — | $0 | 3,893,360 | SEC↗ |
| EW Healthcare Partners-A, L.P. | 10% Owner | P Buy deriv | 2020-03-18 | 2020-03-20 | 519,115 | $25.00 | $12.98M | 519,115 | SEC↗ |
| EW Healthcare Partners-A, L.P. | 10% Owner | P Buy deriv | 2020-03-18 | 2020-03-20 | 156,640 | — | $0 | 156,640 | SEC↗ |
| EW Healthcare Partners-A, L.P. | 10% Owner | P Buy deriv | 2020-03-18 | 2020-03-20 | 20,885 | $25.00 | $522.1K | 20,885 | SEC↗ |
| BARRY RICHARD SCOTT | Director, 10% Owner | P Buy deriv | 2020-03-18 | 2020-03-20 | 156,640 | — | $0 | 156,640 | SEC↗ |
| BARRY RICHARD SCOTT | Director, 10% Owner | P Buy deriv | 2020-03-18 | 2020-03-20 | 519,115 | $25.00 | $12.98M | 519,115 | SEC↗ |
| BARRY RICHARD SCOTT | Director, 10% Owner | P Buy deriv | 2020-03-18 | 2020-03-20 | 3,893,360 | — | $0 | 3,893,360 | SEC↗ |
| BARRY RICHARD SCOTT | Director, 10% Owner | P Buy deriv | 2020-03-18 | 2020-03-20 | 20,885 | $25.00 | $522.1K | 20,885 | SEC↗ |
| Kong Garheng | Director, 10% Owner | P Buy deriv | 2020-03-18 | 2020-03-20 | 900,000 | — | $0 | 900,000 | SEC↗ |
| Kong Garheng | Director, 10% Owner | P Buy deriv | 2020-03-18 | 2020-03-20 | 120,000 | $25.00 | $3.00M | 120,000 | SEC↗ |
| HealthQuest Venture Management | 10% Owner | P Buy deriv | 2020-03-18 | 2020-03-20 | 900,000 | — | $0 | 900,000 | SEC↗ |
| HealthQuest Venture Management | 10% Owner | P Buy deriv | 2020-03-18 | 2020-03-20 | 120,000 | $25.00 | $3.00M | 120,000 | SEC↗ |
| SEDCO Capital Cayman Ltd | 10% Owner | A Award | 2020-03-18 | 2020-03-19 | 660,000 | — | $0 | 1,193,333 | SEC↗ |
| SEDCO Capital Cayman Ltd | 10% Owner | A Award | 2020-03-18 | 2020-03-19 | 1,600,000 | — | $0 | 1,600,000 | SEC↗ |
| Zaring Chad A | Chief Commercial Officer | A Award deriv | 2020-02-11 | 2020-02-13 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Sullivan Keith J | Director | S Sale | 2019-12-09 | 2019-12-10 | 7,184 | $2.91 | $20.9K | 44,133 | SEC↗ |
| Sullivan Keith J | Director | S Sale | 2019-12-06 | 2019-12-10 | 100 | $2.80 | $280 | 51,317 | SEC↗ |
| Sullivan Keith J | Director | S Sale | 2019-12-04 | 2019-12-05 | 200 | $3.15 | $630 | 51,417 | SEC↗ |
| Sullivan Keith J | Director | S Sale | 2019-12-03 | 2019-12-05 | 5,716 | $3.26 | $18.6K | 51,617 | SEC↗ |
| Natale Anthony | Director | A Award | 2019-11-07 | 2022-11-25 | 4,912 | — | $0 | 794,439 | SEC↗ |
| Natale Anthony | Director | A Award | 2019-11-07 | 2022-11-25 | 3,769 | $3.75 | $14.1K | 871,984 | SEC↗ |
| Natale Anthony | Director | A Award | 2019-11-07 | 2022-11-25 | 2,001 | $3.75 | $7.5K | 868,215 | SEC↗ |
| Natale Anthony | Director | A Award | 2019-11-07 | 2022-11-25 | 20,896 | $3.75 | $78.4K | 866,214 | SEC↗ |
| Natale Anthony | Director | A Award | 2019-11-07 | 2022-11-25 | 43,627 | — | $0 | 845,318 | SEC↗ |
| Natale Anthony | Director | A Award | 2019-11-07 | 2022-11-25 | 9,252 | — | $0 | 801,691 | SEC↗ |
| Natale Anthony | Director | A Award | 2019-11-07 | 2022-11-25 | 26,666 | $3.75 | $100.0K | 898,650 | SEC↗ |
| Natale Anthony | Director | A Award | 2019-11-07 | 2022-11-25 | 51,297 | — | $0 | 787,527 | SEC↗ |
| Natale Anthony | Director | A Award | 2019-11-07 | 2022-11-25 | 571,214 | — | $0 | 736,230 | SEC↗ |
| Natale Anthony | Director | A Award | 2019-11-07 | 2022-11-25 | 23,324 | — | $0 | 165,016 | SEC↗ |
| Natale Anthony | Director | A Award | 2019-11-07 | 2022-11-25 | 12,383 | — | $0 | 141,692 | SEC↗ |
| Natale Anthony | Director | A Award | 2019-11-07 | 2022-11-25 | 129,309 | — | $0 | 129,309 | SEC↗ |
| MOLL FREDERIC H | Director | C Conversion deriv | 2019-11-07 | 2019-11-07 | 0 | — | $0 | 0 | SEC↗ |
| MOLL FREDERIC H | Director | C Conversion deriv | 2019-11-07 | 2019-11-07 | 0 | — | $0 | 0 | SEC↗ |
| Georgiadis Anna | VP, Global Human Resources | A Award deriv | 2019-11-07 | 2019-11-07 | 28,835 | — | $0 | 28,835 | SEC↗ |
| Serafino Domenic | Chief Executive Officer | A Award deriv | 2019-11-07 | 2019-11-07 | 5,767 | — | $0 | 5,767 | SEC↗ |
| Serafino Domenic | Chief Executive Officer | A Award deriv | 2019-11-07 | 2019-11-07 | 1,714 | — | $0 | 1,714 | SEC↗ |
| Serafino Domenic | Chief Executive Officer | A Award deriv | 2019-11-07 | 2019-11-07 | 311,003 | — | $0 | 311,003 | SEC↗ |
| Serafino Domenic | Chief Executive Officer | A Award deriv | 2019-11-07 | 2019-11-07 | 293,154 | — | $0 | 293,154 | SEC↗ |
| Serafino Domenic | Chief Executive Officer | A Award deriv | 2019-11-07 | 2019-11-07 | 343,717 | — | $0 | 343,717 | SEC↗ |
| Serafino Domenic | Chief Executive Officer | A Award deriv | 2019-11-07 | 2019-11-07 | 15,586 | — | $0 | 15,586 | SEC↗ |
| Serafino Domenic | Chief Executive Officer | A Award deriv | 2019-11-07 | 2019-11-07 | 5,767 | — | $0 | 5,767 | SEC↗ |
| Iger Yoni | VP Clinical & Reg. Affairs, | A Award deriv | 2019-11-07 | 2019-11-07 | 6,920 | — | $0 | 6,920 | SEC↗ |
| Iger Yoni | VP Clinical & Reg. Affairs, | A Award deriv | 2019-11-07 | 2019-11-07 | 21,914 | — | $0 | 21,914 | SEC↗ |
| Vaynberg Boris | Chief Technology Officer | A Award deriv | 2019-11-07 | 2019-11-07 | 5,333 | — | $0 | 5,333 | SEC↗ |
| Vaynberg Boris | Chief Technology Officer | A Award deriv | 2019-11-07 | 2019-11-07 | 11,534 | — | $0 | 11,534 | SEC↗ |
| Vaynberg Boris | Chief Technology Officer | A Award deriv | 2019-11-07 | 2019-11-07 | 45,271 | — | $0 | 45,271 | SEC↗ |
| Vaynberg Boris | Chief Technology Officer | A Award deriv | 2019-11-07 | 2019-11-07 | 47,001 | — | $0 | 47,001 | SEC↗ |
| Vaynberg Boris | Chief Technology Officer | A Award deriv | 2019-11-07 | 2019-11-07 | 11,534 | — | $0 | 11,534 | SEC↗ |
| Della Penna Domenic | Chief Financial Officer | A Award deriv | 2019-11-07 | 2019-11-07 | 26,663 | — | $0 | 26,663 | SEC↗ |
| Della Penna Domenic | Chief Financial Officer | A Award deriv | 2019-11-07 | 2019-11-07 | 5,767 | — | $0 | 5,767 | SEC↗ |
| Della Penna Domenic | Chief Financial Officer | A Award deriv | 2019-11-07 | 2019-11-07 | 115,341 | — | $0 | 115,341 | SEC↗ |
| Di Sisto Domenic | General Counsel and Corp. Se | A Award deriv | 2019-11-07 | 2019-11-07 | 5,767 | — | $0 | 5,767 | SEC↗ |
| Di Sisto Domenic | General Counsel and Corp. Se | A Award deriv | 2019-11-07 | 2019-11-07 | 57,670 | — | $0 | 57,670 | SEC↗ |
| Di Sisto Domenic | General Counsel and Corp. Se | A Award deriv | 2019-11-07 | 2019-11-07 | 4,613 | — | $0 | 4,613 | SEC↗ |
| Kang Melissa | VP, Global Marketing | A Award deriv | 2019-11-07 | 2019-11-07 | 9,333 | — | $0 | 9,333 | SEC↗ |
| Kang Melissa | VP, Global Marketing | A Award deriv | 2019-11-07 | 2019-11-07 | 14,994 | — | $0 | 14,994 | SEC↗ |
| Kang Melissa | VP, Global Marketing | A Award deriv | 2019-11-07 | 2019-11-07 | 8,073 | — | $0 | 8,073 | SEC↗ |
| Kang Melissa | VP, Global Marketing | A Award deriv | 2019-11-07 | 2019-11-07 | 5,767 | — | $0 | 5,767 | SEC↗ |
| Sinay Soren Maor | Chief Operating Officer | A Award deriv | 2019-11-07 | 2019-11-07 | 66,659 | — | $0 | 66,659 | SEC↗ |
| Sinay Soren Maor | Chief Operating Officer | A Award deriv | 2019-11-07 | 2019-11-07 | 4,325 | — | $0 | 4,325 | SEC↗ |